Our revolutionary AI diagnostic assistant has received official approval from the Saudi Food and Drug Authority (SFDA), marking a landmark achievement in the adoption of artificial intelligence in clinical settings within the Kingdom.
The tool uses advanced deep learning models trained on millions of medical images to assist radiologists in detecting early-stage cancers, cardiovascular anomalies, and neurological conditions with over 96% accuracy.
Clinical trials across three major hospitals demonstrated that the AI assistant reduced diagnostic time by 40% while maintaining accuracy rates comparable to senior specialists.